Calypte Biomedical Corporation, a developer, manufacturer and marketer of HIV diagnostic tests, says its Chinese manufacturing subsidiary, Beijing Marr Bio-pharmaceutical Company, has received a permit to manufacture medical devices issued by the Beijing branch of the Chinese Food and Drug and Administration.

Calypte Biomedical Corporation says its Beijing China manufacturing subsidiary, Beijing Marr Bio-pharmaceutical Co., Ltd., a joint venture between Calypte and a Marr Group subsidiary, has successfully passed its quality system audit and obtained certification of its quality system to the international standard, ISO 13485:2003.